Date: 2016-03-08
Type of information: Nomination
Compound:
Company: Kuros Biosciences (Switzerland)
Therapeutic area: Regenerative Medicine
Type agreement: nomination
Action mechanism:
Disease:
Details: * On March 8, 2016, Kuros Biosciences announced that Dr. Virginia Jamieson has been appointed Chief Medical Officer and member of the Executive Board with immediate effect. Dr. Jamieson has spent over 25 years in the pharmaceutical industry and has considerable experience in early and late stage clinical development, product registration and medical affairs. Dr. Jamieson received her medical degree at Edinburgh University and obtained a postgraduate fellowship in anesthesia from the Royal College of Surgeons in London. In addition, she has a diploma from the Faculty of Pharmaceutical Medicine where she has also been an appraiser for revalidation of physicians in the pharmaceutical industry. Dr. Jamieson already worked for Kuros from 2005 to 2012 as Medical Director and then as Chief Medical Officer and is therefore very familiar with Kuros’ products.
Financial terms:
Latest news:
